References
- Bick R L. Disseminated intravascular coagulation. Current concepts of etiology, pathophysiology, diagnosis, and treatment. Hematol Oncol Clin N Am 2003; 17: 149–176
- Grounds M. Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: A review. Blood Rev 2003; 17: S11–S21
- Roberts H R, Monroe D M, White G C. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 2004; 104: 3858–3864
- Tobias J D. Synthetic factor VIIa to treat dilutional coagulopathy during posterior spinal fusion in two children. Anesthesiology 2002; 96: 1522–1525
- Veldman A, Fischer D, Virgo B, Beyer P A, Schlosser R, Allendorf A, Kreuz N. Life threatening hemorrhage in neonates: Management with recombinant activated FVII. Intensive Care Med 2002; 28: 1635–1637
- Fontaine M J, Lazarchick J, Taylor S, Annibale D. Use of recombinant factor VIIa in infants with severe coagulopathy. J Perinatol 2004; 24: 310–311
- Girish M, Rauch R, Carbon R, Habash T, Hofbeck M. Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: Successful use of recombinant factor VIIa. Eur J Pediatr 2004; 163: 118–119
- Mayer S A. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke 2003; 34: 224–229
- Rice K M, Savidge G F. NovoSeven (recombinant factor VIIa) in central nervous systems bleeds. Haemostasis 1996; 26(Suppl 1)131–134
- Tancabelic J, Haun S E. Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7. Pediatr Blood Cancer 2004; 43: 170–176
- Schulman S, Bech Jensen M, Varon D, Keller N, Gitel S, Horoszowski H. Feasibility of using recombinant factor VIIa in continuous infusion. Thromb Haemost 1996; 75: 432–436
- Lindley C M, Sawyer W T, Macik B G, Lusher J, Harrison J F, Baird-Cox K, Birch K, Glazer S, Roberts H R. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 1994; 55: 638–648
- Erhardtsen E. Pharmacokinetics of recombinant activated factor VII (rFVIIa). Semin Thromb Hemost 2000; 26: 385–391
- Clark A D, Gordon W C, Walker I D, Tait R C. ‘Last-ditch’ use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang 2004; 86: 120–124